Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 13/20 | 1.00 |
| ▸ | HTR2C | P28335 | 10/20 | 1.00 |
| ▸ | HTR2B | P41595 | 9/20 | 1.00 |
| ▸ | HTR1A | P08908 | 6/20 | 1.00 |
| ▸ | HTR6 | P50406 | 2/20 | 1.00 |
| ▸ | DRD1 | P21728 | 1/20 | 1.00 |
| ▸ | HTR1D | P28221 | 1/20 | 1.00 |
| ▸ | HTR1B | P28222 | 1/20 | 1.00 |
| ▸ | HTR1E | P28566 | 1/20 | 1.00 |
| ▸ | ADORA2A | P29274 | 1/20 | 1.00 |
| ▸ | ADORA2B | P29275 | 1/20 | 1.00 |
| ▸ | HTR7 | P34969 | 1/20 | 1.00 |
| ▸ | DRD3 | P35462 | 1/20 | 1.00 |
| ▸ | HTR5A | P47898 | 1/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Psilocin SCHEMBL27221707 | 1.00 | HTR2A (1.00) | HTR2AHTR2CHTR2BHTR1AHTR6 | |
| Psilocin SCHEMBL29363508 | 1.00 | HTR2A (1.00) | HTR2AHTR2CHTR2BHTR1AHTR6 | |
| Psilocin SCHEMBL31188168 | 1.00 | HTR2A (1.00) | HTR2AHTR2CHTR2BHTR1AHTR6 | |
| Psilocin SCHEMBL27169386 | 1.00 | HTR2A (1.00) | HTR2AHTR2CHTR2BHTR1AHTR6 | |
| Psilocin SCHEMBL25193368 | 0.98 | HTR2A (0.97) | HTR2AHTR2CHTR2BHTR1AHTR6 | |
| Psilocin SCHEMBL26646472 | 0.94 | HTR2A (0.89) | HTR2AHTR2CHTR2BHTR1AHTR6 | |
| Psilocin SCHEMBL25174340 | 0.93 | HTR2A (0.86) | HTR2AHTR2CHTR2BHTR1AHTR6 | |
| Psilocin SCHEMBL2761560 | 0.93 | HTR2A (0.86) | HTR2AHTR2CHTR2BHTR1AHTR6 | |
| Psilocin SCHEMBL25184570 | 0.93 | HTR2A (0.86) | HTR2AHTR2CHTR2BHTR1AHTR6 | |
| Psilocin SCHEMBL30785664 | 0.93 | HTR2A (0.86) | HTR2AHTR2CHTR2BHTR1AHTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4016 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144807-A1 | METHOD OF ADMINISTRATION OF A PARENTERAL FORMULATION COMPRISING A PSYCHEDELIC AGENT | CYBIN UK LTD (GB) | 2026-05-28 | — | — | US | claimed |
| US-20260137652-A1 | Composition Comprising Non-Phosphorylated Tryptamine | SINTALICA S R L (IT) | 2026-05-21 | — | — | US | claimed |
| EP-4172145-B1 | TRYPTAMINE PRODRUGS AS SEROTONIN RECEPTOR ACTIVATORS FOR THE TREATMENT OF E.G. DEPRESSION | REUNION NEUROSCIENCE INC (US) | 2026-05-13 | — | — | EP | claimed |
| EP-4734978-A2 | COMBINATION THERAPIES USING PSILOCYBIN | University of Padova (IT) | 2026-05-06 | — | — | EP | claimed |
| US-12616706-B2 | Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic/psychotomimetic dosages and formulations | Arbormentis LLC (US) | 2026-05-05 | — | — | US | claimed |
| US-20260108493-A1 | COMPOSITIONS COMPRISING A SEROTONERGIC TRYPTAMINE COMPOUND | CAAMTECH, INC. (US) | 2026-04-23 | — | — | US | claimed |
| US-20260108544-A1 | TRYPTAMINE COMPOSITIONS FOR ENHANCING NEURITE OUTGROWTH | TURTLE BEAR HOLDINGS LLC (US) | 2026-04-23 | — | — | US | claimed |
| US-12595497-B2 | Processes for the production of tryptamines | COMPASS PATHFINDER LIMITED (GB) | 2026-04-07 | — | — | US | claimed |
| US-20260091047-A1 | THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS | NATIVE CODE BIO LLC (US) | 2026-04-02 | — | — | US | claimed |
| US-20260090957-A1 | Process for making aqueous therapeutic particle having stable exterior water clustering with nanosized thickness | DRESDNER JR KARL P (US) | 2026-04-02 | — | — | US | claimed |
| WO-2005039546-A2 | USE OF INDOLEACETIC ACID DERIVATIVES WHICH INCREASE THE SERUM IGF-1 LEVEL FOR THE PREPARATION OF A THERAPEUTICAL COMPOSITION FOR TREATMENT OF VARIOUS DISEASES | VEIJLEN N.V. (AN) | 2005-05-06 | — | — | WO | claimed |
| WO-2004111185-A2 | DIRECT MICRO-PATTERNING OF LIPID BILAYERS USING UV LIGHT AND SELECTED USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2004-12-23 | — | — | WO | claimed |
| EP-1474126-A2 | TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2004-11-10 | — | — | EP | claimed |
| US-20040180147-A1 | Direct micro-patterning of lipid bilayers using UV light and selected uses thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2004-09-16 | — | — | US | claimed |
| US-20040105881-A1 | Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin | IDEA AG (DE) | 2004-06-03 | — | — | US | claimed |
| WO-2004032900-A1 | AGGREGATE WITH INCREASED DEFORMABILITY, COMPRISING AT LEAST THREE AMPHIPATS, FOR IMPROVED TRANSPORT THROUGH SEMI-PERMEABLE BARRIERS AND FOR THE NON-INVASIVE DRUG APPLICATION IN VIVO, ESPECIALLY THROUGH THE SKIN | IDEA AG (DE) | 2004-04-22 | — | — | WO | claimed |
| WO-2003068147-A2 | TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER’S DISEASE | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2003-08-21 | — | — | WO | claimed |
| WO-2003016903-A2 | DEVICE AND METHOD FOR DETERMINING AN ANALYTE | PILS WALTER (AT) | 2003-02-27 | — | — | WO | claimed |
| US-6306616-B1 | SAMPLES GIVING POSITIVE REACTION IN DIRECT ASSAY TEST ARE TREATED WITH NEUTRALIZING ANTIBODY THAT INHIBITS REACTIVITY OF TRUE ANALYTE, BUT NOT INTERFERING SUBSTANCE | MICROGENICS CORPORATION | 2001-10-23 | — | — | US | claimed |
| EP-0152379-A2 | Process for preparing pharmaceutical compositions containing unilamellar liposomes | CIBA-GEIGY AG (CH) | 1985-08-21 | — | — | EP | claimed |